Related Experiment Video
Updated: Jul 5, 2025

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
Published on: July 19, 2024
Adenosine A1 Receptor and Ligand Molecular Modeling
Mark W Dudley1, Norton P Peet1, David A Demeter1
1Marion Merrell Dow Research Institute, Cincinnati, Ohio.
Researchers discussed ligand design and binding for the adenosine A1 receptor. The N6-C8 model is favored, but specific binding interactions and amino acid roles require further investigation.
Area of Science:
- Pharmacology
- Molecular Biology
- Biochemistry
Background:
- Adenosine A1 receptor is a key target for various therapeutic interventions.
- Understanding ligand binding is crucial for developing selective agonists and antagonists.
- Existing models for ligand interaction require further refinement.
Purpose of the Study:
- To present and discuss current research on adenosine A1 receptor ligand design.
- To achieve consensus on the preferred model of ligand binding.
- To identify key amino acid residues involved in ligand-receptor interactions.
Main Methods:
- Symposium presentations and discussions.
- Review of existing ligand binding models.
- Proposal of site-directed mutagenesis and novel ligand design for testing.
Main Results:
- Agreement on the "N6-C8" model as the preferred mode of ligand binding.
- Identification of two viable, competing models for precise ligand placement within the receptor.
- Recognition of the need for further experimental validation.
Conclusions:
- The "N6-C8" binding mode is widely accepted for adenosine A1 receptor ligands.
- Further research, including site-directed mutagenesis, is necessary to elucidate exact binding site interactions.
- Development of new ligands will aid in distinguishing between proposed binding models.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...